BIOREM INC (BRM.CA) Stock Fundamental Analysis
Canada - TSX-V:BRM - CA09068G1046 - Common Stock
1.9 CAD
0 (0%)
Overall BRM gets a fundamental rating of 7 out of 10. We evaluated BRM against 24 industry peers in the Commercial Services & Supplies industry. Both the health and profitability get an excellent rating, making BRM a very profitable company, without any liquidiy or solvency issues. BRM may be a bit undervalued, certainly considering the very reasonable score on growth This makes BRM very considerable for value and quality investing!
1. Profitability
1.1 Basic Checks
In the past year BRM was profitable.
In the past year BRM had a positive cash flow from operations.
BRM had positive earnings in each of the past 5 years.
BRM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BRM's Return On Assets of 11.60% is amongst the best of the industry. BRM outperforms 91.67% of its industry peers.
BRM has a Return On Equity of 28.73%. This is amongst the best in the industry. BRM outperforms 91.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 25.39%, BRM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BRM is significantly above the industry average of 7.08%.
The 3 year average ROIC (25.13%) for BRM is below the current ROIC(25.39%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.6% | ||
| ROE | 28.73% | ||
| ROIC | 25.39% |
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
1.3 Margins
BRM's Profit Margin of 8.20% is amongst the best of the industry. BRM outperforms 83.33% of its industry peers.
BRM's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 11.72%, BRM is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
In the last couple of years the Operating Margin of BRM has grown nicely.
BRM has a Gross Margin (26.79%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BRM has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.72% | ||
| PM (TTM) | 8.2% | ||
| GM | 26.79% |
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
2. Health
2.1 Basic Checks
BRM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for BRM has been increased compared to 1 year ago.
BRM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRM has an improved debt to assets ratio.
2.2 Solvency
BRM has an Altman-Z score of 3.64. This indicates that BRM is financially healthy and has little risk of bankruptcy at the moment.
BRM's Altman-Z score of 3.64 is amongst the best of the industry. BRM outperforms 87.50% of its industry peers.
The Debt to FCF ratio of BRM is 0.71, which is an excellent value as it means it would take BRM, only 0.71 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.71, BRM belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that BRM is not too dependend on debt financing.
BRM's Debt to Equity ratio of 0.23 is amongst the best of the industry. BRM outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.71 | ||
| Altman-Z | 3.64 |
ROIC/WACC3.35
WACC7.58%
2.3 Liquidity
BRM has a Current Ratio of 1.73. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.73, BRM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.60 indicates that BRM should not have too much problems paying its short term obligations.
BRM has a better Quick ratio (1.60) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
BRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.86%.
The Earnings Per Share has been growing by 32.08% on average over the past years. This is a very strong growth
BRM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.09%.
BRM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.63% yearly.
EPS 1Y (TTM)-27.86%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%9.59%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-28.66%
3.2 Future
BRM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.71% yearly.
Based on estimates for the next years, BRM will show a small growth in Revenue. The Revenue will grow by 7.57% on average per year.
EPS Next Y-5.26%
EPS Next 2Y14.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.08%
Revenue Next 2Y7.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.18 indicates a reasonable valuation of BRM.
91.67% of the companies in the same industry are more expensive than BRM, based on the Price/Earnings ratio.
BRM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.29.
BRM is valuated cheaply with a Price/Forward Earnings ratio of 7.38.
Based on the Price/Forward Earnings ratio, BRM is valued cheaply inside the industry as 95.83% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.85, BRM is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.18 | ||
| Fwd PE | 7.38 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 91.67% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 91.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.92 | ||
| EV/EBITDA | 5.15 |
4.3 Compensation for Growth
BRM has an outstanding profitability rating, which may justify a higher PE ratio.
BRM's earnings are expected to grow with 14.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.71%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BRM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:BRM (10/16/2025, 7:00:00 PM)
1.9
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners2%
Ins Owner ChangeN/A
Market Cap30.59M
Analysts84.44
Price Target3.57 (87.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10%
EPS NY rev (3m)-18.18%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.18 | ||
| Fwd PE | 7.38 | ||
| P/S | 0.8 | ||
| P/FCF | 6.92 | ||
| P/OCF | 6.42 | ||
| P/B | 2.79 | ||
| P/tB | 2.79 | ||
| EV/EBITDA | 5.15 |
EPS(TTM)0.17
EY8.95%
EPS(NY)0.26
Fwd EY13.55%
FCF(TTM)0.27
FCFY14.44%
OCF(TTM)0.3
OCFY15.57%
SpS2.38
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.6% | ||
| ROE | 28.73% | ||
| ROCE | 33.52% | ||
| ROIC | 25.39% | ||
| ROICexc | 59.12% | ||
| ROICexgc | 59.12% | ||
| OM | 11.72% | ||
| PM (TTM) | 8.2% | ||
| GM | 26.79% | ||
| FCFM | 11.52% |
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexcg growth 3Y-30.69%
ROICexcg growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score5
Asset Turnover1.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.71 | ||
| Debt/EBITDA | 0.49 | ||
| Cap/Depr | 60.74% | ||
| Cap/Sales | 0.9% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.04% | ||
| Profit Quality | 140.5% | ||
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.6 | ||
| Altman-Z | 3.64 |
F-Score5
WACC7.58%
ROIC/WACC3.35
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.86%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%9.59%
EPS Next Y-5.26%
EPS Next 2Y14.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.09%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-28.66%
Revenue Next Year1.08%
Revenue Next 2Y7.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.95%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year19.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y370.17%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y533.73%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%